Peer-reviewedCC BYBiomedicines
Advancing the Translational Pipeline: From In Vivo and In Vitro 2D Models to Next-Generation Cell Culture Models for Amyotrophic Lateral Sclerosis Modelling and Drug Discovery
- 1Department of Biological and Environmental Sciences and Technologies (Di.S.Te.B.A.), , 73100 Lecce, Italy; (E.C.); (B.A.T.)
- 2CEDAD (Centre of Applied Physics, Dating and Diagnostics), Department of Mathematics and Physics, , 73100 Lecce, Italy;
Related
- Transcutaneous Carbon Dioxide Monitoring in Amyotrophic Lateral Sclerosis: A Scoping Review
- The value of a family history to distinguish monogenic from polygenic amyotrophic lateral sclerosis
- Amyotrophic Lateral Sclerosis in a Patient Treated for Neurosyphilis: A Case Report
- The prevalence of type 2 diabetes mellitus among people with amyotrophic lateral sclerosis is increasing in the United States
- Cerebrospinal fluid amyloid and neurodegeneration biomarkers in the diagnosis and prognosis of amyotrophic lateral sclerosis: a multicohort observational study
BibTeX
@article{carata2026advancing,
title = {{Advancing the Translational Pipeline: From In Vivo and In Vitro 2D Models to Next-Generation Cell Culture Models for Amyotrophic Lateral Sclerosis Modelling and Drug Discovery}},
author = {Elisabetta Carata and Stefania Mariano and Bernardetta Anna Tenuzzo and Elisa Panzarini},
journal = {Biomedicines},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13701447},
note = {CC BY},
}
RIS
TY - JOUR
TI - Advancing the Translational Pipeline: From In Vivo and In Vitro 2D Models to Next-Generation Cell Culture Models for Amyotrophic Lateral Sclerosis Modelling and Drug Discovery
AU - Elisabetta Carata
AU - Stefania Mariano
AU - Bernardetta Anna Tenuzzo
AU - Elisa Panzarini
PY - 2026
DA - 2026/10/01
JO - Biomedicines
UR - https://europepmc.org/article/PMC/PMC13701447
SN - 2227-9059
ER -